JP2008510828A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008510828A5 JP2008510828A5 JP2007530127A JP2007530127A JP2008510828A5 JP 2008510828 A5 JP2008510828 A5 JP 2008510828A5 JP 2007530127 A JP2007530127 A JP 2007530127A JP 2007530127 A JP2007530127 A JP 2007530127A JP 2008510828 A5 JP2008510828 A5 JP 2008510828A5
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- compound
- group
- methyl
- cyclopropyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 CC(C)c1ccc(*)c2c1CC[C@@](C)[C@@]1C2C1 Chemical compound CC(C)c1ccc(*)c2c1CC[C@@](C)[C@@]1C2C1 0.000 description 2
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60422004P | 2004-08-25 | 2004-08-25 | |
| US60421904P | 2004-08-25 | 2004-08-25 | |
| US60/604,219 | 2004-08-25 | ||
| US60/604,220 | 2004-08-25 | ||
| US68635105P | 2005-05-31 | 2005-05-31 | |
| US60/686,351 | 2005-05-31 | ||
| PCT/US2005/030259 WO2006026356A2 (en) | 2004-08-25 | 2005-08-25 | S-TRIAZOLYL α-MERCAPTOACETANILDES AS INHIBITORS OF HIV REVERSE TRANSCRIPTASE |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012000790A Division JP5457472B2 (ja) | 2004-08-25 | 2012-01-05 | ＨＩＶ逆転写酵素のインヒビターとしてのＳ−トリアゾリルα−メルカプトアセトアニリド |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008510828A JP2008510828A (ja) | 2008-04-10 |
| JP2008510828A5 true JP2008510828A5 (enExample) | 2008-07-17 |
| JP4952943B2 JP4952943B2 (ja) | 2012-06-13 |
Family
ID=36000576
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007530127A Expired - Lifetime JP4952943B2 (ja) | 2004-08-25 | 2005-08-25 | ＨＩＶ逆転写酵素のインヒビターとしてのＳ−トリアゾリルα−メルカプトアセトアニリド |
| JP2012000790A Expired - Lifetime JP5457472B2 (ja) | 2004-08-25 | 2012-01-05 | ＨＩＶ逆転写酵素のインヒビターとしてのＳ−トリアゾリルα−メルカプトアセトアニリド |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012000790A Expired - Lifetime JP5457472B2 (ja) | 2004-08-25 | 2012-01-05 | ＨＩＶ逆転写酵素のインヒビターとしてのＳ−トリアゾリルα−メルカプトアセトアニリド |
Country Status (31)
| Country | Link |
|---|---|
| US (8) | US7947721B2 (enExample) |
| EP (5) | EP1789039B1 (enExample) |
| JP (2) | JP4952943B2 (enExample) |
| KR (1) | KR101241716B1 (enExample) |
| CN (2) | CN101083987B (enExample) |
| AT (2) | ATE528001T1 (enExample) |
| AU (2) | AU2005280130C9 (enExample) |
| BR (2) | BRPI0520870B8 (enExample) |
| CA (1) | CA2578068C (enExample) |
| CY (2) | CY1112221T1 (enExample) |
| DK (1) | DK2135608T3 (enExample) |
| EA (2) | EA014737B1 (enExample) |
| EC (1) | ECSP077322A (enExample) |
| ES (2) | ES2380604T3 (enExample) |
| FR (1) | FR16C0031I2 (enExample) |
| HR (1) | HRP20130075T1 (enExample) |
| HU (1) | HUS1600034I1 (enExample) |
| IL (3) | IL181523A (enExample) |
| IN (1) | IN2014CN03762A (enExample) |
| LT (1) | LTC2135608I2 (enExample) |
| LU (1) | LU93169I2 (enExample) |
| ME (1) | ME01512B (enExample) |
| MX (1) | MX2007002236A (enExample) |
| NL (1) | NL300825I2 (enExample) |
| NZ (2) | NZ553534A (enExample) |
| PL (1) | PL2135608T3 (enExample) |
| PT (1) | PT2135608E (enExample) |
| RS (1) | RS52632B (enExample) |
| SG (2) | SG155246A1 (enExample) |
| SI (1) | SI2135608T1 (enExample) |
| WO (1) | WO2006026356A2 (enExample) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007050087A1 (en) * | 2004-08-25 | 2007-05-03 | Ardea Biosciences, Inc. | N[S(4-aryl-triazol-3-yl)α -mercaptoacetyl]-p-amino benozoic acids AS HIV REVERSE TRANSCRIPTASE INHIBITORS |
| ATE528001T1 (de) * | 2004-08-25 | 2011-10-15 | Ardea Biosciences Inc | S-triazolyl-alpha-mercaptoacetanilide als inhibitoren von hiv-umkehrtranskriptase |
| EP2155692B1 (en) | 2007-05-30 | 2015-06-17 | F. Hoffmann-La Roche AG | Non-nucleoside reverse transcriptase inhibitors |
| WO2009030996A1 (en) * | 2007-09-05 | 2009-03-12 | Coley Pharmaceutical Group, Inc. | Triazole compounds as toll-like receptor (tlr) agonists |
| NZ595035A (en) | 2007-11-27 | 2012-11-30 | Ardea Biosciences Inc | Substituted diazole and triazole compounds and compositions and methods of use |
| US8173690B2 (en) * | 2008-09-04 | 2012-05-08 | Ardea Biosciences, Inc. | Compounds, compositions and methods of using same for modulating uric acid levels |
| US8242154B2 (en) | 2008-09-04 | 2012-08-14 | Ardea Biosciences, Inc. | Compounds, compositions and methods of using same for modulating uric acid levels |
| JP2012502049A (ja) * | 2008-09-04 | 2012-01-26 | アルディア バイオサイエンス，インク． | 尿酸値を調節するための化合物、組成物及びそれを使用する方法。 |
| WO2010048592A1 (en) * | 2008-10-24 | 2010-04-29 | Ardea Biosciences, Inc. | Compositions comprising 4- (2- ( 5-br0m0-4- ( 1-cyclopropylnaphthalen-4-yl) -4h-1, 2, 4-triaz0l-3-ylthi0) acetamido -3-chlorobenzoic acid and pharmaceutically acceptable salts thereof |
| CA2741368A1 (en) * | 2008-10-24 | 2010-04-29 | Barry D. Quart | Compositions comprising 4-(2-(5-bromo-4-(1-cyclopropylnaphthalen-4-yl)-4h-1,2,4-triazol-3-ylthio) acetamido)-3-chlorobenzoic acid and pharmaceutically acceptable salts thereof |
| WO2010135536A2 (en) | 2009-05-20 | 2010-11-25 | Ardea Biosciences, Inc. | Methods of modulating uric acid levels |
| CN102040546B (zh) * | 2009-10-10 | 2014-10-15 | 台州市华南医化有限公司 | 一种4-环丙基-1-异硫氰基萘的制备方法及中间体4-环丙基-1-萘甲醛肟/卤化物 |
| SG182404A1 (en) * | 2010-01-08 | 2012-08-30 | Ardea Biosciences Inc | Polymorphic, crystalline and mesophase forms of sodium 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-ylthio)acetate, and uses thereof |
| US9402827B2 (en) | 2010-03-30 | 2016-08-02 | Ardea Biosciences, Inc. | Treatment of gout |
| US9216179B2 (en) | 2010-06-15 | 2015-12-22 | Ardea Biosciences, Inc. | Treatment of gout and hyperuricemia |
| WO2011159840A2 (en) | 2010-06-16 | 2011-12-22 | Ardea Biosciences, Inc. | Phenylthioacetate compounds, compositions and methods of use |
| AR081930A1 (es) | 2010-06-16 | 2012-10-31 | Ardea Biosciences Inc | Compuestos de tioacetato |
| CN101899013B (zh) * | 2010-07-12 | 2012-07-25 | 山东大学 | 2-(2-取代芳基-2h-1,2,4-三唑-3-巯基)乙酰胺衍生物及其制备方法与应用 |
| US20130296345A1 (en) * | 2010-10-15 | 2013-11-07 | Ardea Biosciences, Inc. | Methods for treating hyperuricemia and related diseases |
| EP2658846B1 (en) | 2010-12-30 | 2016-12-14 | Ardea Biosciences, Inc. | Polymorphic forms of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-ylthio) acetic acid and uses thereof |
| EP2776028B1 (en) | 2011-11-03 | 2018-10-17 | Ardea Biosciences, Inc. | 3,4-di-substituted pyridine compound, methods of using and compositions comprising the same |
| AR091651A1 (es) * | 2012-07-03 | 2015-02-18 | Ardea Biosciences Inc | Elaboracion de acido 2-(5-bromo-4-(4-ciclopropilnaftalen-1-il)-4h-1,2,4-triazol-3-iltio)acetico |
| CN105263913B (zh) * | 2013-06-14 | 2017-12-15 | 广东东阳光药业有限公司 | 硫代1,2,4‑三唑衍生物及其制备方法 |
| CN103524440B (zh) * | 2013-10-15 | 2015-09-09 | 苏州鹏旭医药科技有限公司 | 痛风治疗药Lesinurad的制备方法及Lesinurad中间体 |
| US10351536B2 (en) * | 2013-11-22 | 2019-07-16 | Crystal Pharmatech Co., Ltd. | Crystalline forms of lesinurad and its sodium salt |
| CN104557748A (zh) * | 2014-01-25 | 2015-04-29 | 广东东阳光药业有限公司 | 硫代-1,2,4-三唑衍生物的新的固体形态 |
| CN105315218A (zh) * | 2014-07-17 | 2016-02-10 | 天津药物研究院 | 一种制备lesinurad中间体1-萘基三唑硫酮的方法 |
| CN104341363B (zh) * | 2014-10-27 | 2016-08-17 | 张远强 | 一种硝基取代的三氮唑磺酰丙二酸类化合物、其制备方法及用途 |
| CN104370841B (zh) * | 2014-10-27 | 2016-07-13 | 张远强 | 三氮唑亚磺酰丙二酸类化合物、其制备方法及用途 |
| CN104326993B (zh) * | 2014-10-27 | 2016-08-17 | 张远强 | 一种硝基取代三氮唑亚磺酰丙二酸类化合物、其制备方法及用途 |
| CN104341362B (zh) * | 2014-10-27 | 2016-07-13 | 张远强 | 三氮唑磺酰丙二酸类化合物、其制备方法及用途 |
| CN104370842B (zh) * | 2014-10-27 | 2016-07-13 | 张远强 | 苯基取代的三氮唑磺酰丙二酸类化合物、其制备方法及用途 |
| CN104341361B (zh) * | 2014-10-27 | 2017-01-11 | 张远强 | 一种腈基取代三氮唑亚磺酰丙二酸类化合物、其制备方法及用途 |
| CN104311498B (zh) * | 2014-10-27 | 2016-04-06 | 张远强 | 烷氧基取代的三氮唑磺酰丙二酸类化合物、其制备方法及用途 |
| CN104327000B (zh) * | 2014-10-27 | 2016-08-17 | 张远强 | 苯基取代的三氮唑亚磺酰丙二酸类化合物、其制备方法及用途 |
| CN104326998B (zh) * | 2014-10-27 | 2016-08-17 | 张远强 | 苯基取代的三氮唑丙二酸类化合物、其制备方法及用途 |
| EP3112334A1 (en) | 2015-06-29 | 2017-01-04 | DPx Fine Chemicals Austria GmbH & CoKG | Process for manufacturing 1-cyclopropyl-naphthalenes |
| CN104987311A (zh) * | 2015-06-30 | 2015-10-21 | 安徽万邦医药科技有限公司 | 一种[4-(4-环丙基萘-1-基)-5-硝基- 4h-[1,2,4]三唑-3-基硫烷基]-乙酸乙酯的制备方法及其中间体(5-硝基-4h-[1,2,4]三唑-3-基硫基)-乙酸乙酯 |
| CN105017168A (zh) * | 2015-07-01 | 2015-11-04 | 安徽万邦医药科技有限公司 | 一种[5-溴-4-(4-环丙基萘-1-基)-4h-[1,2,4]三唑-3-基硫烷基]-乙酸甲酯的新制备方法 |
| CN105153056A (zh) * | 2015-07-01 | 2015-12-16 | 安徽万邦医药科技有限公司 | 一种[5-溴-4-(4-环丙基萘-1-基)-4h-[1,2,4]三唑-3-基硫烷基]-乙酸甲酯的新制备方法 |
| WO2017036884A1 (en) | 2015-08-28 | 2017-03-09 | Sandoz Ag | A lesinurad, free form / lesinurad ethyl ester co-crystal |
| CN105566237B (zh) * | 2016-03-01 | 2018-05-18 | 山东大学 | 一种治疗痛风的三唑巯乙酸类化合物的制备方法 |
| KR102329486B1 (ko) | 2016-06-17 | 2021-11-22 | 메드샤인 디스커버리 아이엔씨. | 할로겐화 화합물 및 이의 축상 키랄성 이성질체 |
| EP3281941B1 (en) | 2016-08-11 | 2019-07-24 | Zentiva K.S. | Process for preparing 2-(5-bromo-4-(1-cyclopropylnaphthalen-4-yl)-4h-1,2,4-triazol-3-ylthio)acetic acid |
| EP3372592A1 (en) | 2017-03-07 | 2018-09-12 | Zentiva, k.s. | Solid forms of lesinurad amine salts |
| US10351537B2 (en) * | 2017-03-10 | 2019-07-16 | Apotex Inc. | Processes for the preparation of lesinurad and intermediates thereof |
| EP3315494A1 (en) | 2017-04-19 | 2018-05-02 | Química Sintética, S.A. | Amorphous form of lesinurad and processes for its preparation |
| CN108947919B (zh) | 2017-05-17 | 2023-05-02 | 上海奥博生物医药股份有限公司 | 一种抗痛风药Lesinurad的新型制备方法及其关键中间体 |
| WO2019001325A1 (zh) * | 2017-06-28 | 2019-01-03 | 苏州科睿思制药有限公司 | 雷西纳得的晶型xv及其制备方法 |
| EP3498697A1 (en) | 2017-12-12 | 2019-06-19 | Química Sintética, S.A. | Novel salts and polymorphs of lesinurad |
| DE112022002825T5 (de) | 2021-05-28 | 2024-03-14 | Sumitomo Chemical Company, Limited | Verfahren zur Herstellung von Cycloalkylbromid |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2008A (en) * | 1841-03-18 | Gas-lamp eok conducting gas pkom ah elevated buhner to one below it | ||
| US2006A (en) * | 1841-03-16 | Clamp for crimping leather | ||
| US226186A (en) | 1880-04-06 | Car-coupling | ||
| US2009A (en) * | 1841-03-18 | Improvement in machines for boring war-rockets | ||
| JPS5641637B2 (enExample) | 1973-11-26 | 1981-09-29 | ||
| US6832996B2 (en) * | 1995-06-07 | 2004-12-21 | Arthrocare Corporation | Electrosurgical systems and methods for treating tissue |
| JPH07215940A (ja) | 1994-01-27 | 1995-08-15 | Torii Yakuhin Kk | 抗ウイルス活性を有する化合物 |
| US6245817B1 (en) * | 1997-02-14 | 2001-06-12 | Bayer Corporation | NPY5 receptor antagonists and methods for using same |
| AU6144098A (en) | 1997-02-14 | 1998-09-08 | Bayer Corporation | Amide derivatives as selective neuropeptide y receptor antagonists |
| JPH10243033A (ja) * | 1997-02-28 | 1998-09-11 | Oki Electric Ind Co Ltd | 復調装置 |
| KR100643419B1 (ko) * | 1998-03-27 | 2006-11-10 | 얀센 파마슈티카 엔.브이. | Ｈｉｖ를 억제하는 피리미딘 유도체 |
| JP2002529469A (ja) | 1998-11-12 | 2002-09-10 | ニューロクライン バイオサイエンシーズ， インコーポレイテッド | Ｃｒｆレセプターアンタゴニストおよびそれに関する方法 |
| AU2217200A (en) * | 1998-12-23 | 2000-07-12 | Neurogen Corporation | 2-amino-9-alkylpurines: gaba brain receptor ligands |
| AU763040B2 (en) * | 1998-12-25 | 2003-07-10 | Shionogi & Co., Ltd. | Aromatic heterocycle compounds having HIV integrase inhibiting activities |
| US6593077B2 (en) * | 1999-03-22 | 2003-07-15 | Special Materials Research And Technology, Inc. | Method of making thin films dielectrics using a process for room temperature wet chemical growth of SiO based oxides on a substrate |
| NZ527864A (en) | 2001-03-02 | 2004-05-28 | Smithkline Beecham Corp | Benzophenones as inhibitors of reverse transcriptase |
| JO3429B1 (ar) | 2001-08-13 | 2019-10-20 | Janssen Pharmaceutica Nv | مشتقات برميدينات مثبطة فيروس الايدز |
| WO2003097047A1 (en) | 2002-05-13 | 2003-11-27 | Eli Lilly And Company | Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes |
| EP1545483B1 (en) * | 2002-08-23 | 2011-04-06 | Ardea Biosciences, Inc. | Non-nucleoside reverse transcriptase inhibitors |
| US7642277B2 (en) * | 2002-12-04 | 2010-01-05 | Boehringer Ingelheim International Gmbh | Non-nucleoside reverse transcriptase inhibitors |
| CA2513527C (en) | 2003-02-07 | 2012-08-14 | Janssen Pharmaceutica N.V. | Pyrimidine derivatives for the prevention of hiv infection |
| DE602004031641D1 (de) | 2003-09-25 | 2011-04-14 | Janssen Pharmaceutica Nv | Die replikation von hiv hemmende purinderivate |
| US20080031901A1 (en) * | 2004-09-24 | 2008-02-07 | Abbott Laboratories | Sustained release monoeximic formulations of opioid and nonopioid analgesics |
| US7517998B2 (en) | 2004-06-01 | 2009-04-14 | Boehringer Ingelheim International Gmbh | Non nucleoside reverse transcriptase inhibitors |
| ATE528001T1 (de) | 2004-08-25 | 2011-10-15 | Ardea Biosciences Inc | S-triazolyl-alpha-mercaptoacetanilide als inhibitoren von hiv-umkehrtranskriptase |
| WO2007050087A1 (en) * | 2004-08-25 | 2007-05-03 | Ardea Biosciences, Inc. | N[S(4-aryl-triazol-3-yl)α -mercaptoacetyl]-p-amino benozoic acids AS HIV REVERSE TRANSCRIPTASE INHIBITORS |
| NZ595035A (en) * | 2007-11-27 | 2012-11-30 | Ardea Biosciences Inc | Substituted diazole and triazole compounds and compositions and methods of use |
| CA2741368A1 (en) | 2008-10-24 | 2010-04-29 | Barry D. Quart | Compositions comprising 4-(2-(5-bromo-4-(1-cyclopropylnaphthalen-4-yl)-4h-1,2,4-triazol-3-ylthio) acetamido)-3-chlorobenzoic acid and pharmaceutically acceptable salts thereof |
| WO2010048592A1 (en) | 2008-10-24 | 2010-04-29 | Ardea Biosciences, Inc. | Compositions comprising 4- (2- ( 5-br0m0-4- ( 1-cyclopropylnaphthalen-4-yl) -4h-1, 2, 4-triaz0l-3-ylthi0) acetamido -3-chlorobenzoic acid and pharmaceutically acceptable salts thereof |
| TWM377707U (en) | 2009-09-16 | 2010-04-01 | Nat Energy Technology Co Ltd | Assembly of power supply |
-
2005
- 2005-08-25 AT AT09170772T patent/ATE528001T1/de active
- 2005-08-25 EA EA200700488A patent/EA014737B1/ru not_active IP Right Cessation
- 2005-08-25 SI SI200531426T patent/SI2135608T1/sl unknown
- 2005-08-25 EP EP05790722A patent/EP1789039B1/en not_active Expired - Lifetime
- 2005-08-25 BR BRPI0520870A patent/BRPI0520870B8/pt active IP Right Grant
- 2005-08-25 PT PT09170772T patent/PT2135608E/pt unknown
- 2005-08-25 AT AT05790722T patent/ATE540677T1/de active
- 2005-08-25 EP EP11184025A patent/EP2433633A1/en not_active Withdrawn
- 2005-08-25 EA EA200901186A patent/EA015846B1/ru not_active IP Right Cessation
- 2005-08-25 PL PL09170772T patent/PL2135608T3/pl unknown
- 2005-08-25 EP EP09170772A patent/EP2135608B8/en not_active Expired - Lifetime
- 2005-08-25 US US11/661,079 patent/US7947721B2/en active Active
- 2005-08-25 CA CA2578068A patent/CA2578068C/en not_active Expired - Lifetime
- 2005-08-25 WO PCT/US2005/030259 patent/WO2006026356A2/en not_active Ceased
- 2005-08-25 AU AU2005280130A patent/AU2005280130C9/en not_active Expired
- 2005-08-25 MX MX2007002236A patent/MX2007002236A/es active IP Right Grant
- 2005-08-25 ME MEP-2013-18A patent/ME01512B/me unknown
- 2005-08-25 IN IN3762CHN2014 patent/IN2014CN03762A/en unknown
- 2005-08-25 ES ES05790722T patent/ES2380604T3/es not_active Expired - Lifetime
- 2005-08-25 NZ NZ553534A patent/NZ553534A/en not_active IP Right Cessation
- 2005-08-25 KR KR1020077006746A patent/KR101241716B1/ko not_active Expired - Lifetime
- 2005-08-25 CN CN2005800363729A patent/CN101083987B/zh not_active Expired - Lifetime
- 2005-08-25 EP EP11177941A patent/EP2402011B1/en not_active Expired - Lifetime
- 2005-08-25 BR BRPI0514630A patent/BRPI0514630B8/pt active IP Right Grant
- 2005-08-25 CN CN200910205213.7A patent/CN101817793B/zh not_active Expired - Lifetime
- 2005-08-25 EP EP12187096.8A patent/EP2609917A1/en not_active Withdrawn
- 2005-08-25 NZ NZ581376A patent/NZ581376A/en not_active IP Right Cessation
- 2005-08-25 JP JP2007530127A patent/JP4952943B2/ja not_active Expired - Lifetime
- 2005-08-25 SG SG200905668-0A patent/SG155246A1/en unknown
- 2005-08-25 SG SG2012083366A patent/SG185992A1/en unknown
- 2005-08-25 DK DK09170772.9T patent/DK2135608T3/da active
- 2005-08-25 ES ES09170772T patent/ES2374773T3/es not_active Expired - Lifetime
- 2005-08-25 RS RS20130029A patent/RS52632B/sr unknown
-
2007
- 2007-02-22 IL IL181523A patent/IL181523A/en active IP Right Grant
- 2007-03-15 EC EC2007007322A patent/ECSP077322A/es unknown
-
2009
- 2009-09-23 AU AU2009217458A patent/AU2009217458B2/en not_active Expired
- 2009-10-15 IL IL201546A patent/IL201546A/en not_active IP Right Cessation
- 2009-11-13 US US12/618,604 patent/US20100069645A1/en not_active Abandoned
- 2009-12-08 US US12/633,638 patent/US8003681B2/en not_active Expired - Lifetime
-
2011
- 2011-04-06 US US13/081,398 patent/US8946273B2/en active Active
- 2011-06-30 US US13/174,538 patent/US8252828B2/en not_active Expired - Lifetime
-
2012
- 2012-01-05 JP JP2012000790A patent/JP5457472B2/ja not_active Expired - Lifetime
- 2012-01-11 CY CY20121100023T patent/CY1112221T1/el unknown
- 2012-04-15 IL IL219131A patent/IL219131A0/en unknown
- 2012-07-18 US US13/552,443 patent/US8481581B2/en not_active Expired - Lifetime
-
2013
- 2013-01-29 HR HRP20130075TT patent/HRP20130075T1/hr unknown
-
2014
- 2014-12-03 US US14/559,803 patent/US20150094284A1/en not_active Abandoned
-
2016
- 2016-07-26 LT LTPA2016024C patent/LTC2135608I2/lt unknown
- 2016-07-28 NL NL300825C patent/NL300825I2/nl unknown
- 2016-07-29 FR FR16C0031C patent/FR16C0031I2/fr active Active
- 2016-08-10 CY CY2016028C patent/CY2016028I2/el unknown
- 2016-08-10 LU LU93169C patent/LU93169I2/fr unknown
- 2016-08-17 HU HUS1600034C patent/HUS1600034I1/hu unknown
-
2017
- 2017-02-16 US US15/435,119 patent/US20180002296A1/en not_active Abandoned